Hepatocellular Carcinoma (HCC)

3 competing products in clinical development for Hepatocellular Carcinoma (HCC).

Pipeline by Phase

Phase 12
Phase 31

All Products (3)

ProductCompanyStageStatusHype
Lenvatinib + SorafenibEisaiPhase 3Completed
40
ERY974 + Tocilicumab + Atezolizumab + BevacizumabChugai PharmaceuticalPhase 1Active
33
CT-01 + EVEROLIMUSCaptor TherapeuticsPhase 1Recruiting
26